These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 9471252)

  • 21. Accelerated development and aging of the immune system in p53-deficient mice.
    Ohkusu-Tsukada K; Tsukada T; Isobe K
    J Immunol; 1999 Aug; 163(4):1966-72. PubMed ID: 10438933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of virus-specific CD4+ T cell frequencies from acute infection into long term memory.
    Varga SM; Welsh RM
    J Immunol; 1998 Jul; 161(1):367-74. PubMed ID: 9647245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eosinophil recruitment into sites of delayed-type hypersensitivity reactions in mice.
    Teixeira MM; Talvani A; Tafuri WL; Lukacs NW; Hellewell PG
    J Leukoc Biol; 2001 Mar; 69(3):353-60. PubMed ID: 11261781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma.
    Yuan X; Hu J; Belladonna ML; Black KL; Yu JS
    Cancer Res; 2006 Mar; 66(5):2630-8. PubMed ID: 16510582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional oral tolerance in transgenic 2C mice.
    Margenthaler JA; Flye MW
    Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic dissection of SLE pathogenesis: adoptive transfer of Sle1 mediates the loss of tolerance by bone marrow-derived B cells.
    Sobel ES; Mohan C; Morel L; Schiffenbauer J; Wakeland EK
    J Immunol; 1999 Feb; 162(4):2415-21. PubMed ID: 9973523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic bone marrow inhibits T-cell activation and clonal expansion in vitro.
    George JF; Lu A; Thomas JM; Kirklin JK; Pinderski LJ
    Transplantation; 2003 Jul; 76(1):237-43. PubMed ID: 12865816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Number of lymphocyte subpopulations in the spleen and level of hematopoietic tissue proliferation in mice undergoing surgery].
    Bliakher MS; Gutorova NM; Fedorova IM; Babaeva AG; Iudina NV; Gimmel'farb EI
    Biull Eksp Biol Med; 1996 Mar; 121(3):301-3. PubMed ID: 8688534
    [No Abstract]   [Full Text] [Related]  

  • 29. Changes in various measures of immune status in mice subject to chronic social conflict.
    Gryazeva NI; Shurlygina AV; Verbitskaya LV; Mel'nikova EV; Kudryavtseva NN; Trufakin VA
    Neurosci Behav Physiol; 2001; 31(1):75-81. PubMed ID: 11265820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pheromone inhibitor of aggression in male C57Bl/6 strain laboratory mice].
    Novikov SN; Savvateev VIu
    Dokl Akad Nauk SSSR; 1981; 261(1):211-3. PubMed ID: 7198573
    [No Abstract]   [Full Text] [Related]  

  • 31. Aggressive behavior and lymphocyte damage.
    Richardson JH
    Psychol Rep; 1988 Apr; 62(2):473-4. PubMed ID: 3406263
    [No Abstract]   [Full Text] [Related]  

  • 32. [Social conflict and tumor growth].
    Kaledin VI; Kudriavtseva NN
    Dokl Akad Nauk; 1992; 324(5):1117-20. PubMed ID: 1425190
    [No Abstract]   [Full Text] [Related]  

  • 33. [Changes in immunological reactivity of C57Bl/6 mice during the zoosocial conflict].
    Al'perina EA; Pavina TA
    Biull Eksp Biol Med; 1996 Nov; 122(11):541-3. PubMed ID: 8998347
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of the "partition" test in behavioral and pharmacological experiments.
    Kudryavtseva NN
    Neurosci Behav Physiol; 2003 Jun; 33(5):461-71. PubMed ID: 12921177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Change in the CD4+ T-lymphocyte count in the bone marrow of aggressive CBA mice].
    Idova GV; Pavina TA; Al'perina EP; Devoĭno LV
    Biull Eksp Biol Med; 1997 Nov; 124(11):544-6. PubMed ID: 9471252
    [No Abstract]   [Full Text] [Related]  

  • 36. Regulatory role of CD8+ T lymphocytes in bone marrow eosinophilopoiesis.
    Rådinger M; Sergejeva S; Johansson AK; Malmhäll C; Bossios A; Sjöstrand M; Lee JJ; Lötvall J
    Respir Res; 2006 Jun; 7(1):83. PubMed ID: 16740158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses.
    Yang AS; Lattime EC
    Cancer Res; 2003 May; 63(9):2150-7. PubMed ID: 12727833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new strategy for treatment of malignant tumor: intra-bone marrow-bone marrow transplantation plus CD4- donor lymphocyte infusion.
    Suzuki Y; Adachi Y; Minamino K; Zhang Y; Iwasaki M; Nakano K; Koike Y; Ikehara S
    Stem Cells; 2005 Mar; 23(3):365-70. PubMed ID: 15749931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow retaining colitogenic CD4+ T cells may be a pathogenic reservoir for chronic colitis.
    Nemoto Y; Kanai T; Makita S; Okamoto R; Totsuka T; Takeda K; Watanabe M
    Gastroenterology; 2007 Jan; 132(1):176-89. PubMed ID: 17241870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes in the number of CD4+ T-helpers in the bone marrow of aggressive mice of C57BL/6J and CBA strains].
    Idova GV; Pavina TA; Al'perina EL; Devoĭno LV
    Ross Fiziol Zh Im I M Sechenova; 1998 Apr; 84(4):380-4. PubMed ID: 9742617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.